Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07379697

Measuring Local Potentials in PFA. MULTI PFA (EU)

The Feasibility of Measuring Unipolar Atrial Local Potentials From a Range of Pulsed Field Ablation Catheters. The MULTI PFA (EU) Study

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
CathVision ApS · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study is a prospective, multi-center, exploratory, observational study with the ECGenius® System and the PFAnalyzer software module in PFA cases using the Affera Sphere 9, FaraWave, PulseSelect, Volt or VariPulse PFA systems. The cohort will be adult patients with paroxysmal or persistent atrial fibrillation (AF) who undergo PVI using PFA.

Detailed description

Atrial fibrillation (AF) is the most common cardiac arrhythmia and is associated with a five-fold increase in stroke. Pulmonary vein isolation (PVI) has become a first-line treatment for paroxysmal AF. PVI is achieved by ablating cardiac tissue around the pulmonary veins. Until recently, this has been achieved using thermal energy. However, more recently a new energy source known as pulsed field ablation (PFA) has been introduced. As PFA is tissue selective, it preserves the function of nearby structures such as the esophagus and phrenic nerve making it safer to use. As PFA is delivered in short bursts of high energy, it is also more efficient and leads to shorter procedures. However, the catheters designed to deliver PFA differ to those used previously and do not provide the same information about efficacy, making it more difficult for the operator to ascertain if the lesions have successfully isolated the pulmonary vein. This exploratory observational study will assess the utility of a software module designed to measure the local potential derived from the unipolar electrogram recorded at the electrode that has delivered the PFA. During the procedure, the study will collect data only and all analysis of the output of the PFAnalyzer software module will be made off-line once the procedure is complete. The operator will follow the hospital's standard of care during the procedure, and the software module will not be used to guide therapy, nor will there be any additional time added to the procedure. The study is a prospective, multi-center, exploratory, observational study with the ECGenius® System and the PFAnalyzer software module in PFA cases using the Affera Sphere 9, FaraWave, PulseSelect or VariPulse PFA systems. The cohort will be adult patients with paroxysmal or persistent atrial fibrillation (AF) who undergo PVI using PFA.

Conditions

Timeline

Start date
2026-04-28
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2026-01-30
Last updated
2026-03-17

Source: ClinicalTrials.gov record NCT07379697. Inclusion in this directory is not an endorsement.